Pipeline for Stroke and Heart Disease Drugs is Encouraging
Heart disease, according to the Centers for Disease Control and Prevention (CDC), is the leading cause of death for both men and women. With so many Americans succumbing to the disease every year it is not surprising that a significant number of biopharmaceutical companies are concentrating their efforts on developing new therapies targeting various cardiovascular disorders. A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) has identified 215 potential therapies currently in the pipeline indicated for heart disease and stroke.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter